Shilpa Medicare zooms on getting nod to manufacture, market Lenvatinib capsules

01 Feb 2020 Evaluate

Shilpa Medicare is currently trading at Rs. 307.00, up by 40.60 points or 15.24% from its previous closing of Rs. 266.40 on the BSE.

The scrip opened at Rs. 265.00 and has touched a high and low of Rs. 311.75 and Rs. 263.70 respectively. So far 6711 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 433.10 on 23-Apr-2019 and a 52 week low of Rs. 190.80 on 04-Sep-2019.

Last one week high and low of the scrip stood at Rs. 311.75 and Rs. 253.80 respectively. The current market cap of the company is Rs. 2267.67 crore.

The promoters holding in the company stood at 53.80%, while Institutions and Non-Institutions held 26.89% and 19.31% respectively.

Shilpa Medicare has received approval from Central Drugs Standard Control Organisation (CDSCO) -New Delhi to manufacture and market Lenvatinib capsules 4mg and 10mg in India. It is the first company to obtain Generic approval for Lenvatinib Capsules 4mg and 10mg in India.

Lenvatinib capsules 4mg and 10mg is a generic equivalent of reference product, Lenvima, used in the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer and for the first line treatment of patients with unresectable hepatocellular carcinoma. According to IQVIA MAT Q2 2019 data, the Indian market for Lenvatinib capsules 4mg and 10mg is approximately $0.32 million.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.


Shilpa Medicare Share Price

331.30 -2.65 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×